Observations on improving Covid-19 vaccination responses in Kidney Transplant Recipients: heterologous vaccination and immunosuppression modulation
Solid organ transplant recipients have a weaker humoral response to Covid-19 vaccination due to several factors, including lymphopenia associated with immunosuppressive therapies (particularly Belatacept, antiproliferative drugs and steroids)1. Due to the high probability of severe Covid-19 symptoms in this at-risk population2, a third vaccine dose has been proposed for immunocompromised patients by the French National Authority for Health in order to improve humoral responses and vaccine efficiency3.
Source: Kidney International - Category: Urology & Nephrology Authors: Christophe Masset, Simon Ville, Claire Garandeau, Florent Le Borgne, Thibaut Letellier, Diego Cantarovich, Aur élie Meurette, Cécile Guillot-Gueguen, Maxime Bentoumi-Loaec, Magali Giral, Jacques Dantal, Gilles Blancho Tags: letters to the editor Source Type: research
More News: COVID-19 | France Health | Kidney Transplant | Kidney Transplantation | Transplant Surgery | Transplants | Urology & Nephrology | Vaccines